24.50p-0.75 (-2.97%)02 Dec 2021, 16:10
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Deepverge PLC Fundamentals

Company NameDeepverge PLCLast Updated2021-12-02
IndustryHealth Information ServicesSectorHealthcare
Shares in Issue215.156 mMarket Cap£52.71 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0885Debt Equity Ratio0.0560
Asset Equity Ratio1.3347Cash Equity Ratio0.3000
Quick Ratio2.3583Current Ratio2.83
Price To Book Value2.1473ROCE0

Deepverge PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Deepverge PLC Company Financials

Tangible Assets£1.44 m£974,000.00£32,000.00
Intangible Assets£18.24 m£3.65 m£718,000.00
Total Fixed Assets£20.04 m£5.34 m£1.46 m
Stocks£1.35 m£85,000.00£135,000.00
Debtors£1.27 m£468,000.00£140,000.00
Cash & Equivalents£1.44 m£1.19 m£26,000.00
Other Assets000
Total Assets£24.27 m£7.16 m£1.80 m
Creditors within 1 year£4.61 m£1.04 m£2.17 m
Creditors after 1 year£3.75 m£1.04 m£414,000.00
Other Liabilities00£563,000.00
Total Liabilities£8.35 m£2.08 m£2.59 m
Net assets£15.92 m£5.09 m-£784,000.00
Called up share capital£166,000.00£108,000.00£46,000.00
Share Premium£34.59 m£21.26 m£13.18 m
Profit / Loss-£2.90 m-£2.40 m-£1.52 m
Other Equity£15.13 m£5.09 m-£784,000.00
Preference & Minorities£789,000.0000
Total Capital Employed£15.92 m£5.09 m-£784,000.00
Debt Ratio£0.06£0.100
Assets / Equity1.33471.33471.3347
Cash / Equity0.30000.30000.3000
Cash Flow202020192018
Cash from operating activities-£2.21 m-£2.27 m-£950,000.00
Cashflow before financing£293,000.00£1.50 m£814,000.00
Increase in Cash£248,000.00£1.17 m£71,000.00
Turnover£4.48 m£823,000.00£274,000.00
Cost of sales£2.64 m£221,000.00£126,000.00
Gross Profit£1.84 m£602,000.00£148,000.00
Operating Profit-£2.72 m-£2.37 m-£1.48 m
Pre-Tax profit-£2.90 m-£2.40 m-£1.52 m

Deepverge PLC Company Background

ActivitiesDeepverge PLC is a scientific research company focused on the production and analysis of bacteria, viruses, and toxins utilizing artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for global cosmetic company clients to remotely detecting water contamination in real-time.
Latest Interim Date15 Sep 2021
Latest Fiscal Year End Date30 Jun 2021

Deepverge PLC Directors

2019-05-02Mr. Donald Nicholson Executive Director
2021-06-30Dr. Nigel John Burton Non-Executive Director
2021-11-26Mr. Gerard James Brandon Executive Director,Chief Executive Officer
2020-09-16Mr. Anthony Francis Richardson Non-Executive Director,Chairman
2018-08-06Mr. Paul Francis Kennedy Non-Executive Director
2021-04-13Mr. Ross Martin Hilton Andrews Non-Executive Director,Chairman
2018-07-17Mr. Declan James Service Executive Director,Chief Executive Officer
2018-08-06Mr. Helmut Schlieper Executive Director
2018-08-29Mr. Christopher Bell Executive Director,Chief Financial Officer and Company Secretary
2021-11-26Mr. Camillus Gerard Glover Executive Director,Chief Financial Officer
2021-06-30Mr. Fionan Murray Executive Director,Chief Operating Officer

Deepverge PLC Contact Details

Company NameDeepverge PLC
AddressYork Biotech Campus, Sand Hutton, NAFIC, York, YO41 1LZ
Telephone+44 1904404036

Deepverge PLC Advisors

BankUlster Bank Group
AuditorJeffreys Henry LLP
Phone+44 2073092222
Fax+44 2073092309
RegistrarNeville Registrars Ltd
Phone+44 1215851131
Fax+44 1215851132
SolicitorBPE Solicitors LLP
Phone+44 1242224433
Fax+44 1242574285
Financial PR AdviserCardew Group
Phone+44 2079300777
Fax+44 2079250647
Nominated AdviserSpark Advisory Partners Limited
Phone+44 2033683550
StockbrokerTurner Pope Investments (TPI) Ltd
Phone+44 2036214120